Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment in the United States (with exclusive co-development partner, Ambio, Inc.) Read More
Ambio Announces US FDA Approval of a Generic Version of Forteo® (Teriparatide Injection) for its partner Apotex Read More
Adalvo announces successful launch of Icatibant in close collaboration with strategic partner Ambio Read More
